Published in G Ital Cardiol on January 01, 1987
How sound is the evidence that thrombolysis increases the risk of cardiac rupture? Br Heart J (1993) 0.86
Raman spectrum of graphene and graphene layers. Phys Rev Lett (2006) 16.04
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation (2000) 2.81
Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. Br J Psychiatry (1999) 2.50
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. Chest (1994) 2.32
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med (1993) 1.81
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation (1993) 1.74
Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Arch Intern Med (1994) 1.72
Proposal for a new definition of congenital complete atrioventricular block. Lupus (2003) 1.70
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Risk factors for myocardial infarction in young women. Am J Epidemiol (1987) 1.55
Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol (2001) 1.49
Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J (2001) 1.48
Persistent tardive dyskinesia: demographic and pharmacological risk factors. Acta Psychiatr Scand (1993) 1.48
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J (2002) 1.45
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Dis (2001) 1.45
The origin of brain metastases in patients with an undiagnosed primary tumour. Acta Neurochir (Wien) (2004) 1.44
Trends in perinatal, neonatal and postneonatal mortality in Italy, 1955-84. Soz Praventivmed (1987) 1.41
Antibiotic treatments of a methicillin-resistant Staphylococcus pseudintermedius infection in a dog: a case presentation. Schweiz Arch Tierheilkd (2011) 1.39
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J (1999) 1.36
Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol (1993) 1.34
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32
Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation (1997) 1.32
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland. Support Care Cancer (1996) 1.23
Internet for clinical trials: past, present, and future. Control Clin Trials (1999) 1.21
Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators. Circulation (1992) 1.20
Lung changes in rheumatoid arthritis: CT findings. Radiology (1994) 1.19
Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials. Psychol Med (1994) 1.19
Tar yield of cigarettes and risk of acute myocardial infarction. GISSI-EFRIM Investigators. BMJ (1993) 1.17
Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol (1989) 1.16
p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer. Eur J Cancer (2000) 1.15
A new 2D-based method for myocardial velocity strain and strain rate quantification in a normal adult and paediatric population: assessment of reference values. Cardiovasc Ultrasound (2009) 1.15
A model to control data flow in multicenter clinical trials. Methods Inf Med (1995) 1.13
Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer (1985) 1.13
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate? Ann Oncol (1993) 1.12
Telepathology using Internet multimedia electronic mail: remote consultation on gastrointestinal pathology. J Telemed Telecare (1996) 1.10
Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris. Eur J Cardiol (1979) 1.10
The case of GISSI in changing the attitudes and practice of Italian cardiologists. Stat Med (1990) 1.09
Characteristics of women undergoing induced abortion: results of a case-control study from Northern Italy. Contraception (1985) 1.08
Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction. Catheter Cardiovasc Interv (2000) 1.05
A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin. Eur J Cancer Clin Oncol (1985) 1.05
Delayed poststroke dementia: a 4-year follow-up study. Neurology (2004) 1.03
Passive smoking and the risk of acute myocardial infarction GISSI-EFRIM investigations. Lancet (1993) 1.03
Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574). Cancer Chemother Rep (1974) 1.01
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol (1997) 0.99
trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages. Int J Cancer (1993) 0.97
Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification study. Lung Cancer (2011) 0.96
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma. Eur J Cancer (2001) 0.96
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol (2006) 0.95
Pattern of therapeutic intervention and role of psychiatric settings: a survey in two regions of Italy. Acta Psychiatr Scand (1987) 0.95
Is anticoagulation therapy underused in elderly patients with atrial fibrillation? Drugs Aging (1997) 0.94
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial. J Intern Med (2010) 0.94
Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users. Neurol Sci (2002) 0.93
Pericardial tamponade as initial presentation of papillary thyroid carcinoma. Eur J Surg Oncol (2005) 0.92
Alcohol consumption and the risk of breast cancer in women. J Natl Cancer Inst (1985) 0.91
[Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico]. G Ital Cardiol (1995) 0.91
A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis. J Am Coll Cardiol (1994) 0.91
Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects. Eur J Clin Pharmacol (1997) 0.90
Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion (1995) 0.90
Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia. J Clin Psychopharmacol (1999) 0.90
Parental age and risk of complete and partial hydatidiform mole. Br J Obstet Gynaecol (1986) 0.89
Effects of glucocorticoid therapy on urine protein-to-creatinine ratios and renal morphology in dogs. J Vet Intern Med (1997) 0.89
Dietary vitamin A and the risk of invasive cervical cancer. Int J Cancer (1984) 0.89
Neuroretinitis in acquired syphilis. Ophthalmology (1985) 0.89
Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol (1999) 0.88
[PROCARDIS: A current approach to the study of the genetics of myocardial infarct]. Ital Heart J Suppl (2001) 0.88
In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med (1987) 0.88
Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol (1982) 0.87
GISSI-2: mortality plus extensive left-ventricular damage as "end-point". Lancet (1990) 0.87
Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer (1991) 0.87
Isolation and characterization of Clostridium difficile from shellfish and marine environments. Folia Microbiol (Praha) (2011) 0.86
Radiation therapy duration influences overall survival in patients with cervical carcinoma. Int J Gynaecol Obstet (1997) 0.85
Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer. Ann Oncol (1990) 0.85
Indium-111 pentetreotide lung uptake in infectious lung disease. Clin Nucl Med (1999) 0.85
Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients. Cancer Immunol Immunother (1995) 0.85
Median sternotomy and multiple lung resections for metastatic sarcomas. Eur J Cardiothorac Surg (1990) 0.84
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. J Am Coll Cardiol (1997) 0.84
Improving compliance in depression: a systematic review of narrative reviews. J Clin Pharm Ther (2006) 0.84
Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer. Schweiz Med Wochenschr (2000) 0.84
Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases. Eur J Surg (2000) 0.83
Medulloblastoma. Results of a sequential combined treatment. Cancer (1984) 0.83